What You Should Know:
- Today, Komodo Health unveiled a new self-service solution for rapid patient cohort analysis and insight generation.
- MapView is the industry’s first and most sophisticated analytics application that allows users without data science expertise to easily extract insights from Komodo’s Healthcare Map. MapView is designed to accelerate decision-making across the Life Sciences enterprise by generating powerful, automated business intelligence for every team and at every stage of the Life Sciences product life cycle, from clinical development and medical strategy to commercialization.
Revolutionizing Healthcare Analysis: MapView’s Accelerated Insight Generation in MapLab Platform
MapView, part of the MapLab platform, accelerates healthcare analysis by automating insights generation through pre-designed templates tailored to industry needs. It enables real-time analysis of disease trends, treatment paths, patient demographics, and more, utilizing Komodo’s analytics tools and proprietary Healthcare Map. Users can integrate custom datasets for enhanced filtering. A recent survey highlighted challenges in accessing and understanding real-world data in Life Sciences, including time constraints, data quality issues, and lack of expertise.
This transformation is exemplified by a recent analysis conducted by Komodo using MapLab to illuminate the current treatment landscape for multiple sclerosis (MS) patients. MapView facilitated analysts in examining the sequence and timing of events throughout the patient journey, from diagnosis to treatment, and swiftly generating easily comprehensible patient cohort reports regarding gender distribution, age demographics, payer channels, and prescribed medications — all achieved within minutes. These insights shed light on previously unknown patterns in MS treatment, potentially aiding patients and healthcare providers in making more informed decisions, while also enabling Life Sciences firms to swiftly pinpoint populations that could benefit from transformative therapies.
MapLab stands out as the sole integrated suite of applications designed to streamline the insight generation process, empowering companies to unlock advanced insights efficiently. From pre-designed dashboards and customizable data analytics workflows to advanced data science and modeling capabilities, MapLab assists companies in leveraging RWD to comprehend and gauge the impact of their strategic endeavors and bridge care gaps for their patients. MapView is presently accessible to Life Sciences teams, including Commercial, Medical Affairs, and Clinical Development, as well as Life Sciences consultancies. Additional MapLab applications and tailored offerings for specific segments, including Komodo’s new generative AI analytics co-pilot, are slated for release throughout 2024.
“MapLab modernizes the insights workflow and shifts business leaders away from costly, time-intensive, one-off analytics projects that are impossible to scale, stifle innovation, and have plagued our industry for decades,” said Web Sun, President and Co-Founder, Komodo Health. “Investing in MapLab and the newly launched MapView application takes you away from having to manage multiple data partners, armies of consultants, and implementing endless tools and processes, to having one unified platform to generate insights that drive critical business decisions in an efficient manner across the entirety of the enterprise.”
